SCHEMBL20070113

SCHEMBL20070113

CN1CCC(N)(NC(=O)C2CCCN2C)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 1/20 0.43
WNT1 P04628 1/20 0.36
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
PARP1 P09874 2/20 0.34
CNR2 P34972 1/20 0.33
HSD11B1 P28845 3/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KCNK3 O14649 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
PTGER4 P35408 1/20 0.31
L3MBTL3 Q96JM7 1/20 0.31
CASP1 P29466 1/20 0.30
JAK2 O60674 1/20 0.30
JAK3 P52333 1/20 0.30
F2 P00734 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2604735 0.76 CYP3A4 (0.46) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL12733477 0.75 CYP3A4 (0.44) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL20158532 0.74 RET (0.49) CYP3A4CYP2D6CNR2ALDH1A1PTGER4
SCHEMBL2604728 0.74 CYP3A4 (0.43) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL15626080 0.73 CYP3A4 (0.51) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL15745586 0.73 CYP3A4 (0.51) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL14289638 0.73 CYP3A4 (0.51) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL21651941 0.73 RET (0.37) CYP3A4CYP2D6
SCHEMBL172515 0.71 CYP3A4 (0.53) CYP3A4CYP2D6WNT1GSK3BDYRK1A
SCHEMBL490080 0.71 CYP3A4 (0.53) CYP3A4CYP2D6WNT1GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed